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Abstract. A stochastic spatial model based on the Monte Carlo approach
is developed to study the dynamics of human immunodeficiency virus (HIV)
infection. We aim to propose a more detailed and realistic simulation
frame by incorporating many important features of HIV dynamics, which
include infections, replications and mutations of viruses, antigen recognitions,
activations and proliferations of lymphocytes, and diffusions, encounters and
interactions of virions and lymphocytes. Our model successfully reproduces the
three-phase pattern observed in HIV infection, and the simulation results for
the time distribution from infection to AIDS onset are also in good agreement
with the clinical data. The interactions of viruses and the immune system in all
the three phases are investigated. We assess the relative importance of various
immune system components in the acute phase. The dynamics of how the two
important factors, namely the viral diversity and the asymmetric battle between
HIV and the immune system, result in AIDS are investigated in detail with the
model.
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Acquired immunodeficiency syndrome (AIDS) has rapidly emerged as one of the main global
health problems. Since the time when the human immunodeficiency virus (HIV) was first
isolated in 1983 [1] and was confirmed to be the cause of AIDS in 1984 [2, 3], intensive studies
have been carried out to understand the complex interactions between viruses and the immune
system and to unravel the dynamics of the ultimate failure of the immune system in fighting
against HIV. There are two types of HIV: HIV-1 and HIV-2. In the present paper, we will only
consider HIV-1 that is responsible for the great majority of infections worldwide.
The immune system can protect the host from viral infections. Most viruses, after infecting
humans, are rapidly cleared during the initial acute stage of infection or establish a long-term
asymptomatic chronic infection due to a mutual compromise of the virus and the immune
system. But the pattern of disease progress in HIV infection is different. A typical HIV infection
can be subdivided into three phases [4]. During the first 2–6 weeks after HIV entering the host,
the acute phase occurs. Viral load (the number of virions in the peripheral blood) increases
dramatically followed by a fall of the helper T lymphocytes (CD4+T cells). Patients usually
show symptoms similar to flu in this phase. Then during the 9th to the 12th week, the viral
load experiences a sharp decline and the number of CD4+T cells returns almost to their normal
level. With the viral load falling to a very low level, the clinical symptoms disappear. However,
the viruses cannot be completely eliminated after primary infection unlike most other viral
infections, and patients enter the second phase, which is a long period of the asymptomatic
stage (clinical latency) lasting for 1–10 years or more. During this phase, viral load remains
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very low, while the CD4+T cell population continues to decline slowly until it becomes lower
than a critical value. Finally, the viral load climbs up again, resulting in an onset of AIDS.
In such a final phase, the impaired immune system can no longer fight off infections, and
patients usually die from a variety of opportunistic infections [5] that would normally be
cleared.
What made the HIV different from the other pathogens? From more than 20 years of
intensive studies, people have obtained an in-depth understanding of many aspects of HIV
dynamics. Nowadays, it is well known that there are two prominent mechanisms of the HIV
infection. Firstly, HIV preferentially infects and kills the CD4+T cells [6, 7], which are one of
the master regulators of the immune system required for the CD8+ cytotoxic T cells and B cells
to respond to viruses. Therefore, the progressive depletion of CD4+T cells in the HIV infection
eventually results in the loss of many cell-mediated immunological functions that are essential
for effective defenses, and causes the patients to have a high susceptibility to opportunistic
infections and malignancies. Secondly, HIV has a high mutation rate [8]–[11] because its reverse
transcriptase lacks the proofreading mechanism. So the viruses can create highly diverse quasi-
species [12] and escape recognition by the host’s immune effector cells [10]. Although there
are different perspectives on why the HIV infection displays a three-phase pattern [13]–[15], it
is generally believed that the two distinguishing features mentioned above are the most likely
causes of HIV’s avoiding clearance and ultimate failure of the immune system. However, how
these two mechanisms promote long-term co-evolution of viruses and the host immune system
and induce the transition from the asymptomatic phase to development of AIDS still remains
obscure and requires further investigation.
Nowadays, mathematical modeling has become an integral part of the research on the
HIV infection. Elaborate mathematical models cannot only help further understanding of
HIV dynamics [16]–[18], but also provide useful predictions that can be used as the basis
for assessing the effects of chemotherapy or immunotherapy and for the design of optimum
therapies and effective vaccines [16, 18].
Several mathematical models using ordinary differential equations (ODE) have been
developed to investigate the dynamics of HIV infection [19]–[21]. Nowak et al [19, 20]
proposed ‘antigenic diversity threshold theory’, suggesting that beyond a threshold of antigenic
diversity, the immune system loses control over the viral population, triggering a high rebound
in viral load and onset of AIDS. The Wang–Deem model [21] postulated that the competition
among the different strains of T cells degrades immune control of viral infection and, finally,
allows HIV to escape from the immune system. These models have successfully reproduced
the three-state dynamics and contributed significantly to the understanding of the mechanisms
of HIV infection. However, these mathematical models are limited to systems of ODE
describing spatio-temporal averaged behavior and cannot capture the stochastic properties of
HIV dynamics.
Recently, cellular automata (CA) models have been used in HIV modeling [22]–[24]. The
interactions of HIV and the immune system are described by a set of simple local transition
rules in CA models, and these models have shown great potential for simulating the temporal
and spatial dynamics of HIV infection. But this kind of approach has its own limitations. Firstly,
the inter-cellular interaction rules used in CA models are usually very simple, and it is hard to
demonstrate the plentiful realistic virus–host interactions in HIV infection. Secondly, mobility
is an important feature of virions and immune cells in the real immune system, whereas in most
of the CA models [22, 24] the cells are unmovable.
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In this paper, we proposed a stochastic spatial model with moderate complexity to model
HIV dynamics. As opposed to the well-mixed population model, a spatially explicit model can
take into account the local interactions and the spatial inhomogeneities. These features are of
central importance since viral propagation and the immune response are fundamentally local
processes [22, 23]. We propose a more detailed and realistic simulation frame by incorporating
many important features of HIV dynamics, including infections, replications and mutations
of viruses, antigen recognitions, activations and proliferations of lymphocytes, and diffusions,
encounters and interactions of virions and lymphocytes. Compared to the ODE approaches, our
model explicitly considers the stochastic characters of HIV infection. We also integrate more
plentiful interactions between viruses and the immune system in our model than in previous CA
models. Our simulation results are in good agreement with the clinical observations both at the
individual level of three-phase HIV development and at the population level of AIDS onset time
distribution.
2. Model
Simulations are carried out on a two-dimensional L × L square lattice. Three types of mobile
individuals, CD4+T cells, CD8+T cells and HIV virions, are distributed on the lattice sites. Each
lattice site can contain at most one individual of a certain type, but it can be simultaneously
occupied by two or more individuals of different types.
2.1. The random diffusion of cells and virions
At each simulation step, which is equivalent to one day in real life, each individual can move
randomly to a nearby site in the migration neighborhood of size (2rm + 1) × (2rm + 1) (the Moore
neighborhood of range rm). Hence, rm stands for the maximum distance an individual can travel
in a day. Such a stochastic diffusion process can be simulated as follows [26]: a virion or a
lymphocyte selects randomly a site in the migration neighborhood rm. If the selected site has
been occupied by the same type of individual, the two individuals will swap their position;
otherwise, the individual will move to the selected site.
2.2. Binary string model of virus and T cell
Lymphocytes recognize antigens through the surface receptors, such as B-cell receptors (BCRs)
and T-cell receptors (TCRs) [27]. The receptors bind specifically to molecules from the antigen
and elicit the immune response. In our model, both antigen epitopes on viruses and antigen-
specific receptors on T cells are represented by binary strings of length l [28]. Hence, the





(1 − δani ,anj ), (1)
where ani and a
n
j denote the bit values at the nth site of the viral string ai and the T cell’s string
a j , and δlm is the Kronecker delta.
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2.3. The infection of CD4+T cells by viruses
The primary cellular receptor for HIV entry into a target cell is CD4, a molecule expressed on the
surface of helper T lymphocytes and other immune cells [29]. The binding of the HIV envelope
glycoprotein to CD4 and coreceptors initiates a series of conformational changes leading to
membrane fusion and viral entry [30, 31]. Upon infection, viral RNA can be reverse transcribed
into double-stranded DNA. During this step the mutations may occur because the process of
reverse transcription is extremely error-prone [8]. Next, the viral DNA is transported to the
nucleus and integrated into the host chromosomes. Hence, the virus can reproduce itself using
the machinery of the host cell, and finally the cell dies and releases the viruses that can further
infect other cells [32].
Accordingly, we model the infection process as follows: a virion will invade a healthy
CD4+T cell with a probability pv if they meet at the same site. Following the assumption made
in previous models [19, 21, 22], here we do not consider the multiple infections [33]; thus a
virion cannot invade an infected cell. We also exclude the HIV recombination [34] and ignore
the fitness cost [35] of the viral mutant in the model. All of these restrictions can be relaxed in
principle, but doing so will lead to considerable complexity. Then during the process of reverse
transcription the viral binary string will be mutated with a probability mv. For simplicity, we
assume that in each transcription step at most one bit site is to be mutated. Therefore, when
mutation occurs, a random site of the binary string is selected to flip the bit value from ‘1’ to ‘0’
or from ‘0’ to ‘1’.
An infected CD4+T cell will produce a new virus with a probability rv at each simulation
step. The binary string of the progeny virus is the same as the viral DNA (either mutated or
unmutated) carried by the infected cell. Once the number of viruses in a given cell exceeds a
lysis threshold nlys, the cell dies and the progeny virions are released and randomly dispersed
on the lattice sites in the Moore neighborhood of range rv. To mimic a finite carrying capacity
of the system, only one virion selected at random can survive if two or more progeny virions
occupy the same lattice site and the others are removed. This approach is also applied to model
the finite carrying capacity of the system for the CD4+T cells and CD8+T cells.
2.4. The proliferation of CD4+T cells
Clonal expansion of CD4+T cells [36]–[38] is a necessary step in most adaptive immune
responses. CD4+T cells recognize antigen-derived peptides bound to major histocompatibility
complex (MHC) class II molecules that are exposed on the surface of antigen presenting cells
(APC). The CD4+T cells will then become activated and begin to proliferate, secrete cytokines
and differentiate into memory T cells.
For simplicity, in the model we do not distinguish different states of the CD4+T cells, i.e.
the naïve T cells, the activated T cells and the memory T cells. We do not take into account
the APCs either. At each simulation step, the coincidence of a virion and a healthy CD4+T cell
leads to both infection (with probability pv) and cell proliferation with a probability pi j , where
the subscripts denote the viral strain i and the CD4+T cell clone j . Thus, the effects of APCs
are represented implicitly via the parameter pi j . Since the matching of an antigen with a TCR
may not be exact but approximate [39]–[41], we assume that the activation probability depends
exponentially on the Hamming distance between the virus and the cell [21]
pi j = p0 exp(−αhi j), (2)
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where p0 is the activation probability when the binary strings perfectly match between the HIV
and the cell. The parameter α regulates to what degree pi j depends on the Hamming distance.
Upon clone extension, the activated CD4+T cell will produce nx offspring that are dispersed
randomly in the Moore neighborhood of range rx . Here we also consider the finite carrying
capacity of the system described above.
2.5. The proliferation of CD8+T cells and the killing of infected CD4+T cells
Once inside the CD4+T cell, viruses become hijackers, using the cell’s machinery to produce
more viruses. During this process some viral proteins synthesized by the cell are degraded into
oligopeptides, a fraction of which are transported into the endoplasmic reticulum (ER). In the
ER, these peptides bind to MHC class I molecules and the resulting complexes are transported to
the cell surface for antigen presentation [42]–[44]. Thus CD8+T cells can detect viral infections
by monitoring the cell surface. On recognition of viral antigens, CD8+T cells become activated
and begin to proliferate, and most of its progenies become effector cells that can recognize and
kill the infected cells [45, 46].
According to the way of interaction between CD8+T cells and infected CD4+T cells, we
assume that when a CD8+T cell meets an infected CD4+T cell in which the virus has already
begun to be reproduced, the CD4+T cell will be killed with a probability ki j and all of the
viruses inside the cell are removed. Meanwhile, the CD8+T cell will be triggered to proliferate
with a probability p′i j and produces ny offspring that are dispersed randomly in the Moore
neighborhood of range ry . The subscripts of the p′i j denote the viral strains i inside the infected
cell and the CD8+T cell clone j . In order to consider the cross-reactivities, we assume that the
activation probability and the killing probability also depend on the Hamming distance
p′i j = p
′
0 exp(−αhi j), (3)
ki j = k0 exp(−αhi j), (4)
where p′0 and k0 are the corresponding probabilities when hi j = 0, and α is a regulation
parameter as defined in equation (2).
2.6. The help of CD4+T cells to B cells
CD4+T cells do not kill viruses directly. Their main function is to help the B cells and CD8+T
cells to develop fully to fight the infection. For a resting B cell to become activated and produce
antibodies, signals provided by the CD4+T cells are required. These signals enable the B cells
to proceed to proliferate and differentiate into the antibody-secreting cells [47]. Therefore, with
the help of CD4+T cells, B cells can kill the virions more effectively, which means that the viral
mortality rate depends indirectly on the number of virus-specific CD4+T cells.
Based on the above considerations, in order to model the help of CD4+T cells to B cells,
we simply assume that the death rate of free virions is a function of the concentration of the
virus-specific CD4+T cells, and the B cells do not appear explicitly in our model for the sake of
simplicity. Thus, the death probability of a free virion (strain i) in one day is given as
dvi = dv0 + (1 − dv0) ×
[CD4i ]
θ + [CD4i ]
. (5)
The first term dv0 is the helper-independent natural death probability of a virion in one day, and
the second term stands for the regulation of viral mortality probability by [CD4i ], the density
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of virus-specific CD4+T cells. Here, we assume that the dependence has the form of the Hill
function f (x) = xn/(θ n + xn) with order n = 1, which is often used to represent an unknown
regulation function in biology systems [50]. Parameter θ in the Hill function is the density or
the concentration yielding half-maximal expression.
2.7. The help of CD4+T cells to CD8+T cells
The exact mechanisms of how the CD4+T cells deliver help to the CD8+T cells are still unclear.
Many experiments [25, 51] suggest that the primary response of CD8+T cells develops normally
in the absence of help, while the efficient restimulation of memory CD8+T cells appears to
require some help. Therefore, with the help of CD4+T cells, the CD8+T cells can persist at
elevated levels in the long term.
Accordingly, in our model we simply assume that the CD8+T cells have a relatively high
mortality rate without help, but have a long lifespan in an environment of plentiful virus-specific





θ + [CD4i ]
)
. (6)
Here, the regulation function of CD4+T cells is also approximated by a Hill function, and
parameter dy0 denotes the helper-independent natural death probability of a CD8+T cell in one
day.
2.8. Replenishment of T cells
In a healthy human body, the T cell loss can be fully compensated by replenishment of new
naïve cells from the thymus [52]. Therefore, in our model we assume that the new T cells are
generated at a constant rate λ. Since the concentration of the T cells must be kept at a steady state
without viral infection, the replenishment rates of the CD4+T cells and CD8+T cells are given
by λx = x0dx0 and λy = y0dy0, respectively, where x0 and y0 denote the initial concentration of
CD4+T cells and CD8+T cells before viral infection. The newborn cells, whose binary strings
are drawn randomly from a uniform distribution, are dispersed to the randomly chosen empty
sites at each simulation step.
3. Results
3.1. Parameter settings
Simulations have been carried out on a lattice of size N = 100 × 100 with periodic boundary
conditions. At the beginning, we disperse randomly over the whole lattice CD4+T cells and
CD8+T cells with random binary strings, and the initial virions with only one sequence of genes.
Since the epitope of the antigen is 8–11 amino acids long [21, 53], we set the length of binary
string to l = 10.
In our model, the death probability of a healthy CD4+T cell in one day is dx0 = 0.01 [54].
Considering that the death rate of infected CD4+T cells is 0.1 day−1 [10], which means that
the average lifespan of an infected cell is 10 days, we set the lysis threshold nlys = 5 and the
probability that an infected cell generates a new virion in one day bv = 0.5. Thus, the average
time from infection to lysis of an infected CD4+T cell is 10 days.
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Table 1. The parameters used for simulations.
Parameter Value Explanation
l 10 Length of binary string
v0 0.03 Initial viral density
x0 0.8 Initial density of CD4+T cells
y0 0.1 Initial density of CD8+T cells
rm, rv, rx , ry 3 Migration range or dispersion range
pv 0.8 Probability that a virion infects a healthy CD4+T cell
bv 0.5 Probability that an infected cell generates a new virion in one day
mv 5.5 × 10−5 Probability that viral mutation occurs during reverse transcription
nlys 5 Lysis threshold of infected CD4+T cells
p0, p′0 0.8 Baseline probability that a T cell is activated by a virion
nx , ny 5 Number of offspring produced during proliferation of T cells
k0 0.8 Probability that a virion is killed by a CD8+T cell
dv0 0.01 Helper-independent natural death probability of a virion in one day
dx0 0.01 Death probability of a healthy CD4+T cell in one day
dy0 0.1 Helper-independent death probability of a CD8+T cell in one day
α 1.0 Regulation parameter in equations (2)–(4)
θ 0.5 Regulation parameter in equations (5) and (6)
We are only concerned with the dynamics of activated CD8+T cells, which have a relatively
high death rate (0.1 day−1) compared with the naïve cells. However, for simplicity, we do not
distinguish between activated T cells and naïve T cells; therefore in our model, the density of the
initial CD8+T cells, which is used as a background to elicit primary cellular immune responses,
is set to a very low level at y0 = 0.1.
The other parameters used in the model are as given in table 1 unless specified otherwise.
3.2. Three-phase dynamics
The time evolution of HIV, CD4+T cells and CD8+T cells at the individual level for three
samples and at the population level are given in figures 1(a)–(d), respectively. Figures 1(a)–(c)
show three simulation samples corresponding to three individuals with AIDS onset occurring
about 10, 2 and 15 years after infection. All the samples reproduce the three-phase pattern
observed in the dynamics of HIV infection [4]. The results show a high level of viral load and a
sudden drop of CD4+T cells after infection, followed by a rapid increase of CD8+T cells. With
the viral number declining to a very low level in a few weeks, the CD8+T cells go through
a contraction process and then return to a relatively high level in asymptomatic phase. These
results are consistent with clinical observation [59]. Different from CD8+T cells, CD4+T cells
are depleted gradually during the whole incubation period. Finally, the exhaustion of the pool of
CD4+T cells results in two effects, i.e. the lack of stimulation by the infected CD4+T cells and
the lack of help provided by the healthy CD4+T cells, which lead to a sudden drop in CD8+T
cells and a rebound of viruses.
Figure 1(d) shows the average evolution of HIV infection at the population level. The
results are averaged over 10 000 simulation samples (corresponding to 10 000 HIV-infected
individuals) with different initial configurations. The large fluctuation, i.e. the large error bars,
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Figure 1. (a–c) Time evolution of HIV, CD4+T cells and CD8+T cells in different
individuals with AIDS onset occurring about 10, 2 and 15 years after infection.
(d) Average dynamics of HIV infection. The results are averaged over 10 000
samples. The error bars are for standard deviations.
of the results, especially shown in the incubation period, indicates the great diversity in disease
development among different individuals. It was found that, on average, the growth of viruses
and the decline of CD4+T cells are approximately linear during the asymptomatic phase, while
at the individual level the transition is abrupt, as shown in figures 1(a)–(c). Deterministic
models based on ODE or well-mixed population models based on mean-field approximation can
usually capture only the average behaviors, while spatial models, of which the localizations, the
inhomogeneities and the stochasticities are natural ingredients, can yield qualitatively different
behaviors from the averaged results.
3.3. The acute phase
A newly HIV-infected individual has plenty of uninfected cells that are suitable for the viruses
to infect and reproduce, which induces a transient increase of the viral load in the acute phase.
However, viral number will decline rapidly to a very low level in a few weeks. Most studies
postulated that the fall in viral load is due to the host’s immune response, including HIV-specific
humoral (B cell) response [56] and the cellular (CD8+T cell) immune response [57]–[59]. Some
investigations have suggested that the decrease of viral number is simply a result of population
dynamics [17], i.e. as more and more healthy CD4+T cells become infected and die, the infection
of the virions becomes more difficult, resulting in the decline of viruses. Therefore, it is still
unclear to what extent the immune responses are involved in the reduction of viral load during
primary HIV infection.
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Figure 2. Time evolution of HIV, CD4+T cells and CD8+T cells in the acute
phase (a) without immune response, (b) with only humoral response, (c) with
only cellular response and (d) with fully immune response. The results are
averaged over 10 000 simulations. The black lines are for HIV, red lines for
CD4+T cells and blue lines for CD8+T cells.
In order to discuss this problem, we show in figure 2 the time evolution of our model in
the acute phase in four different conditions, i.e. without immune response (p0 = 0 and p′0 = 0),
with only humoral response (p0 = 0.8 and p′0 = 0), with only cellular response (θ → ∞ in
equation (5)) and with fully immune response.
Our simulation results shown in figure 2 indicate that the three mechanisms, i.e. lack of
target cells, and the humoral and cellular immune responses, contribute to the reduction of viral
load in acute infection, but the cellular response plays a decisive role in suppressing the viral
load. If the host’s immune system does not respond to the infection (p0 = 0 and p′0 = 0), there
is only a small decline in viral load, as shown in figure 2(a). Hence, the lack of target cells
has no significant effects on HIV dynamics in the acute phase. When the absence of CD8+T
cells is simulated with p0 = 0.8 and p′0 = 0, we see a considerable degree of virus decline, but
there still are relatively high levels of viruses in the host (figure 2(b)). However, it was found
that the absence of neutralizing antibody (θ → ∞ in equations (5)) does not influence the viral
dynamics in the acute phase, as shown in figure 2(c). Our results on the decisive role of the
cellular response are consistent with the observation in experimental studies that the relatively
poor clearance of virus occurred when the CD8+T cell response was delayed [57].
It has been reported that the CA model proposed by dos Santos and Coutinho [22] is
sensitive to the initial density of the infected cell. If the value of this parameter is lower than
0.05, then the acute phase disappears [60]. We also investigate the sensitivity of our presented
model to the initial viral density v0. The simulation results indicate that even if the initial
viral density v0 is set to 0.002, our model can reproduce the three-phase pattern successfully.
However, the time needed for the viral load to reach the peak increases with decreasing v0, while
the peak value is insensitive to v0 (figure 3). We also find that the global properties of the HIV
dynamics are not influenced by the initial viral load (data not shown).
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Figure 3. Sensitivity of the HIV dynamics to the initial viral density v0 in the
acute phase. (a) The day that the viral density reach the peak. (b) The peak value
of viral density. The results are averages over 10 000 simulations. The error bars
are for the standard deviations.
3.4. The asymptomatic phase
As shown in figures 1 and 2, HIV elicits a strong immune response, which effectively suppresses
the viral load to a very low level. But it raises the question of why this response fails ultimately
to eliminate the virus. In the following, we show that the answer may lie in the high mutation
rate of HIV.
The emergence of viral mutants plays a major role in HIV infection for virus to escape
immune responses [9]. To assess the effect of viral mutation on HIV disease progression, we
study the viral and cellular dynamics in the absence of viral mutation (mv = 0). The result shown
in figure 4(a) indicates that the system converges to an equilibrium state that the viruses persist
at a very low level and cannot be totally eliminated by the immune system. Then we increase the
viral genetic diversity by setting the virus binary string length to l = 1, 2 and 3, which means
that the total number of different strains in a viral quasi-species is M = 2, 4 and 8, respectively
(figures 4(b)–(d)). It can be seen that by increasing the viral diversity, the system becomes more
and more unstable. Each emergence of a new viral mutant induces an outbreak of viruses and an
abrupt drop in CD4+T cells, followed by a strong response of CD8+T cells to suppress viral load
to a low level again, and then the CD4+T cells return to a normal level. Therefore, the system
can tolerate some degree of viral diversity. However, once the viral diversity exceeds a threshold
(l = 4, corresponding to M = 16 in our model) the immune system is no longer able to control
HIV, resulting in the onset of AIDS, as shown in figure 4(e).
In order to further investigate the evolution of viral quasi-species and virus-specific
immune response, we track the birth–death processes of viral mutant strains and virus-specific
T-cell clones. Figure 5 demonstrates that the viral mutant appears in the early stage of the
asymptomatic phase. Then, over a long period of time, only a small number of new strains
emerge and they are then suppressed to a very low level by the specific immune response.
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Figure 4. The time evolution of the HIV system at different viral mutation
diversities. (a) The system converges to an equilibrium state if the viral mutation
rate mv = 0. (b)–(d) As the viral diversity increases, i.e. M = 2 for (b), M = 4
for (c) and M = 8 for (d), the system becomes more and more unstable. (e) Once
the viral diversity exceeds a threshold (l > 4 with M > 16), the immune system
is no longer able to control the HIV. The black lines are for HIV, red lines for
CD4+T cells and blue lines for CD8+T cells.
Therefore, the immune system is totally dominant in this stage. However, in the late stage of the
asymptomatic phase (from about the 2000th day to the 4000th day in figure 5), emergence of
new viral strains become much more frequent. Although new types of specific T-cell clones will
be generated to fight these mutants, the mutant viruses will have already produced new types of
viral mutations before they are cleared. Consequently, with the accumulation of viral mutations,
the immune system cannot function any more to respond to so many viral strains (after about
the 4000th day in figure 5).
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Figure 5. Evolution of (a) HIV, (b) CD4+T cells and (c) CD8+T cells. The
lines with different colors are for different viral strains and corresponding virus-
specific T-cell clones.
Why can the immune system not control HIV if there are too many viral mutants? The
answer is that the fight between HIV and the immune system is asymmetry, i.e. a given CD4+T
cell clone can only recognize a corresponding specific viral strain, while any viral strain can
infect all susceptible CD4+T cells regardless of their specificity [25]. Therefore, if there are too
many viral strains in the host, each T-cell clone can fight only a small fraction of the viruses, but
has a lot of chances to be infected and killed by the whole viral population. Such an asymmetry
battle leads to the continual depletion of CD4+T cells, which finally results in the destruction of
the whole immune system. The simulation results shown in figure 6 demonstrate this process.
It can be seen from an individual sample given in figures 6(a) and (b) that in the late stage
of the asymptomatic phase the number of viral strains begin to overtake that of the virus-
specific T-cell clones, which starts the collapse of the immune system. The results shown in
figures 6(c) and (d) are averaged over 10 000 simulation samples. It was found that for each
type of virus, its growth is followed by the expansion of the corresponding CD4+T and CD8+T
cells, which in turn reduces virus growth, leading the system toward equilibrium. The repeat of
such a process gives oscillations for virus and immune cells. This phenomenon can also be seen
in other models [12, 25]. Note that in figure 6, we plot each day’s data, whereas in figure 1,
in order to facilitate comparison between the simulation results and the clinical data [4], we
record only each year’s data after the first 130 days; therefore the oscillations cannot be shown.
However, as the number of viral strains increases more rapidly than the number of T cells, the
equilibrium can no longer be maintained, and the T-cell population gradually loses the ability
to keep up with the evolution of viral quasi-species. Finally, the immune system loses the fight
against HIV, resulting in the onset of AIDS.
Besides the oscillation of virus and immune cells, the results shown in figure 6 also provide
a prediction about how the viral diversities and divergences evolved in the HIV infection. We
found that the virus strain number increases most of the time, followed by a growing increase
of strain number before the onset of AIDS, which may, in principle, be tested by advanced
sequencing technology.
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Figure 6. Time evolution of (a) the number of HIV strains and virus-specific
T-cell clones and (b) their corresponding densities for an individual sample.
(c, d) The corresponding results averaged over 10 000 samples. The black lines
are for HIV, red lines for CD4+T cells and blue lines for CD8+T cells.
3.5. The onset of AIDS
There are a lot of statistical data from various studies about the incubation period distribution
in the development of AIDS [61]. Much effort has been spent on parametric estimates of
the waiting time from HIV infection (seroconversion) to the onset of AIDS [62], while
some research works applied an alternative approach such as percolation theory to study the
characteristics of the time course of HIV infection [63]. Here, we used our model to investigate
the time distribution from HIV seroconversion to AIDS onset.
The CD4+T cell count is usually adopted as a predictor of progression of HIV infection.
It has been reported that the CD4+T cell count, immediately after seroconversion, is about
800 cells µl−1 [64, 65]. When the CD4+T cell count falls to 350 cells µl−1, HIV-related
opportunistic infections begin to appear, and at 200 cells µl−1 the person is classified as having
AIDS regardless of the appearance of other opportunistic infections [65]. Consequently, in our
model, we set the initial density of the CD4+T cells to 0.8, and define the onset of AIDS as the
CD4+T cells density falls to 0.2. The simulation results shown in figure 7 describe the proportion
developing AIDS with time from seroconversion. It was found that the time distribution from
HIV infection to AIDS onset is greatly influenced by the viral mutation rate mv. By setting
mv = 5.5 × 10−5, our simulation result is in good agreement with the clinical data from [61] on
the AIDS development at population level.
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Figure 7. Development of AIDS from seroconversion. The results were obtained
from 10 000 simulation samples. The lines represent the simulation results with
the black dash-dot line for mv = 4.5 × 10−5, the solid red line for mv = 5.5 ×
10−5 and the blue dash line for mv = 6.5 × 10−5. The red circles are the clinical
data from [61].
4. Discussion
We investigate the dynamics of HIV infection based on a stochastic spatial model, which
incorporates the interactions between viruses and the immune system in a more detailed and
realistic manner than previous models. Firstly, we consider the random mobilities of virions and
cells, and define the individual interactions of HIV and the immune system components in terms
of probabilities and rates. Therefore, our model explicitly incorporates the stochastic characters
of the HIV dynamics, which enables us to study the great diversity of disease development
among different individuals, and to investigate the time distribution from infection to AIDS
onset. Secondly, we distinguish two different T-cells, namely, CD4+T cells and CD8+T cells,
which are collectively treated as a single entity in previous models [19]–[22], [24]. We also
consider the help of CD4+T cells to B cells and CD8+T cells. Hence, we can assess the relative
importance of various immune system components in fighting against the viruses. Thirdly, the
introduction of a binary string model facilitates our study of the evolution of viral quasi-species
and virus-specific T-cell population.
The simulation results are in good agreement with the clinical observations, both at the
individual level and at the population level. At the individual level, the three-phase pattern of
HIV infection is reproduced successfully. The interactions of viruses and the immune system
in all the three phases were investigated in detail. We assessed the relative importance of
various immune system components in the acute phase and found that the CD8+T cells play
a decisive role in suppressing the viral load. This observation implies that stimulation of a
CD8+T cell response might be an important goal in the development of an effective vaccine
against AIDS [57]. We have observed the viral diversity threshold phenomena postulated
by Nowak et al [19]. However, in the Nowak model [19], the viruses will be cleared if
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the production rate of new viral mutants is too low, whereas in our model the immune
response cannot completely eliminate the viruses even if in the absence of viral mutation. By
distinguishing the different entries of lymphocytes, we can use a biologically more realistic
model to simulate the asymmetric battle, a concept proposed in previous studies [19, 20, 25],
between HIV mutant strains and immune cell clones. Furthermore, we are able to show
how the viral mutation rate is largely responsible for the HIV dynamics, and we obtain,
at the population level, incubation period distributions that are consistent with the clinical
data [61].
Although our model has taken into account many of the important features of HIV
infection, it is still simple compared with the real interactions between HIV and the immune
system. For example, the B cell and the APC did not appear explicitly in our model, and we
did not take into account the fact that the viral size is much smaller than the lymphocyte size.
Thus, a lattice site can accommodate only one virion, as for the lymphocyte. For simplicity,
we also assume that the migration and dispersion range of virions in one day is the same as
that of cells. However, this restriction is not necessary, for the simulation results do not show
any differences even for a diffusion velocity of virions 10 times faster than that of cells (data
not shown). Many of the parameters of our relatively simple model are set quite arbitrarily; for
example, the distances that T cells and virions move, the number of progeny virions released
from the infected cell, and the mutation rate of virus do not strictly correspond to those
in vivo [66, 67]. Therefore, our model needs to be further developed. More types of lymphocytes
can be added to the system, and we can allow more than one virion to occupy the same lattice
site so that multiple infection is permitted, and the sensitivity of the model to the choice of
parameters should be tested, which will be the subject of our further research. However, in spite
of all these simplifications in our present model, the simulation results capture many observed
features of HIV infection quite well and may contribute to a better understanding of AIDS
disease.
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